Lista de obras -

<i>Bundibugyo ebolavirus</i> Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling

artículo científico publicado en 2021

A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge

artículo científico publicado en 2019

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

artículo científico publicado en 2022

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

artículo científico publicado en 2022

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus

artículo científico publicado en 2023

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever

artículo científico publicado en 2022

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease

An introduction to the Marburg virus vaccine consortium, MARVAC

artículo científico publicado en 2022

Animal Models for Henipavirus Research

artículo científico publicado en 2023

Antibodies periodically wax and wane in survivors of Ebola

artículo científico publicado en 2021

Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants

artículo científico publicado en 2019

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease

artículo científico publicado en 2022

Current state of Ebola virus vaccines: A snapshot

artículo científico publicado en 2021

Early transcriptional changes within liver, adrenal gland and lymphoid tissues significantly contribute to Ebola pathogenesis in cynomolgus macaques

artículo científico publicado en 2020

Establishment of an African green monkey model for COVID-19

artículo científico publicado en 2020

Establishment of an African green monkey model for COVID-19 and protection against re-infection

artículo científico publicado en 2020

Immune correlates of postexposure vaccine protection against Marburg virus

artículo científico publicado en 2020

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants.

artículo científico

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase

artículo científico publicado en 2020

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase

artículo científico publicado en 2020

Marburg and Ravn Viruses (Filoviridae)

artículo científico publicado en 2021

Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus

scholarly article

Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona

artículo científico publicado en 2023

Natural history of infection in rhesus and cynomolgus macaques

artículo científico publicado en 2022

Oral administration of obeldesivir protects nonhuman primates against <i>Sudan ebolavirus</i>

artículo científico publicado en 2024

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates

scholarly article by Courtney Woolsey et al published 22 November 2018 in Journal of Infectious Diseases

Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease

artículo científico publicado en 2023

Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity

artículo científico publicado en 2019

The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms

artículo científico publicado en 2023

Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates

artículo científico publicado en 2024

Transcriptional analysis of lymphoid tissues from infected nonhuman primates reveals the basis for attenuation and immunogenicity of an Ebola virus encoding a mutant VP35 protein

scientific article published on 06 January 2021

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis

artículo científico publicado en 2017

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates

artículo científico publicado en 2021

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates

artículo científico publicado en 2020

Lista de obras de

<i>Bundibugyo ebolavirus</i> Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling

A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease

An introduction to the Marburg virus vaccine consortium, MARVAC

Animal Models for Henipavirus Research

Antibodies periodically wax and wane in survivors of Ebola

Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease

Current state of Ebola virus vaccines: A snapshot

Early transcriptional changes within liver, adrenal gland and lymphoid tissues significantly contribute to Ebola pathogenesis in cynomolgus macaques

Establishment of an African green monkey model for COVID-19

Establishment of an African green monkey model for COVID-19 and protection against re-infection

Immune correlates of postexposure vaccine protection against Marburg virus

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants.

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase

Marburg and Ravn Viruses (Filoviridae)

Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus

Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona

Natural history of infection in rhesus and cynomolgus macaques

Oral administration of obeldesivir protects nonhuman primates against <i>Sudan ebolavirus</i>

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates

Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease

Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity

The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms

Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates

Transcriptional analysis of lymphoid tissues from infected nonhuman primates reveals the basis for attenuation and immunogenicity of an Ebola virus encoding a mutant VP35 protein

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates